Pegylated interferon-2b-associated autoimmune thrombocytopenia in a patient with chronic hepatitis C.
Sevastianos
V A
VA
Deutsch
M
M
Dourakis
S P
SP
Manesis
E K
EK
D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001327:Autoimmune Diseases / Q000139:chemically induced* / Q000276:immunology; D005260:Female; D006526:Hepatitis C / Q000150:complications; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects*; D008103:Liver Cirrhosis / Q000188:drug therapy* / Q000821:virology; D011092:Polyethylene Glycols; D011994:Recombinant Proteins; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000276:immunology
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C417083:peginterferon alfa-2b; C100416:peginterferon alfa-2a